Analysts’ Viewpoint
The global brachytherapy seeds market is expected to witness significant growth in the next few years. Brachytherapy is a form of radiation therapy used to treat various types of cancer, including prostate, breast, and cervical cancer. Increase in incidence of cancer across the world and rise in demand for minimally invasive treatment options are driving market expansion. Furthermore, favorable reimbursement policies and increased awareness about the benefits of brachytherapy are expected to propel global brachytherapy seeds market growth.
Technological advancements in brachytherapy techniques offer lucrative opportunities to market players. Companies are focusing on development of new and improved brachytherapy seeds in order to increase market share and revenue. However, stringent regulatory guidelines and high cost of treatment could hamper global brachytherapy seeds market development.
Brachytherapy seeds are small radioactive sources that are implanted directly into the tumor or surrounding tissues to deliver targeted radiation therapy. These seeds are typically made of metals such as iodine-125, palladium-103, or cesium-131, which emit radiation to destroy cancer cells.
Brachytherapy seeds, also known as radiation seeds, are used in various cancer treatments, including prostate cancer, breast cancer, gynecological cancers, head & neck cancers, and lung cancer. The seeds are inserted into the body using specialized applicators or needles, guided by imaging techniques such as ultrasound, CT scan, or MRI.
Surge in incidence of cancer, particularly prostate, breast, and gynecological cancers, is driving the global brachytherapy seeds market value. Cancer continues to be a leading cause of morbidity and mortality across the world, with millions of new cases diagnosed each year. This growing prevalence of cancer has created a need for effective and targeted treatment options, spurring the demand for brachytherapy seeds.
Prostate cancer is one of the most common cancers among men globally. Brachytherapy has emerged as a preferred treatment option for localized prostate cancer due to its ability to deliver precise radiation directly to the tumor site.
Brachytherapy seeds, such as iodine-125 or palladium-103, are implanted into the prostate gland, where they emit radiation to destroy cancer cells. Increase in incidence of prostate cancer, especially in aging population, has fueled demand for brachytherapy seeds.
Breast cancer is a significant health concern, particularly among women. Brachytherapy seeds offer an alternative to traditional whole-breast radiation therapy for early-stage breast cancer.
Surge in incidence of cancer can be attributed to various factors, including aging population, lifestyle changes, environmental factors, and improved cancer screening and diagnosis. As the number of cancer cases continues to rise globally, there is a greater emphasis on finding effective treatment options that offer better outcomes and quality of life for patients. Brachytherapy seeds, with their targeted and minimally invasive approach, align with these needs, driving their demand in the market.
Growing preference for minimally invasive treatments is a significant driver of the global brachytherapy seeds market size. Brachytherapy, as a minimally invasive treatment option, offers several advantages over traditional surgical and external beam radiation therapies, which is bolstering its adoption.
Minimally invasive procedures are characterized by smaller incisions, reduced trauma to tissues, shorter recovery times, and fewer postoperative complications. Brachytherapy aligns with these characteristics, as it involves the precise placement of radioactive seeds directly into the tumor or surrounding tissues, minimizing damage to healthy tissues and organs.
One of the key advantages of brachytherapy is its ability to deliver targeted radiation therapy. By placing the radiation source close to the tumor site, brachytherapy seeds can provide a high dose of radiation precisely to the cancerous cells while sparing healthy tissues. This targeted approach enhances treatment efficacy and reduces the risk of complications and side effects associated with traditional therapies.
Compared to open surgery or external beam radiation therapy, brachytherapy also offers a shorter treatment duration. In several cases, the seeds can be implanted in a single session or a few sessions, eliminating the need for prolonged hospital stays or frequent treatment visits. This not only reduces the burden on patients but also optimizes healthcare resource utilization.
Rise in preference for minimally invasive procedures stems from multiple factors. Patients are increasingly seeking treatment options that minimize the invasiveness of procedures and offer faster recovery times. Additionally, healthcare providers are recognizing the benefits of minimally invasive techniques in terms of patient outcomes, reduced healthcare costs, and resource optimization.
In terms of radioactive seed type, the iodine-125 segment accounted for the largest global brachytherapy seeds market share in 2022. Iodine-125 seeds are widely used in brachytherapy due to favorable characteristics, including a half-life suitable for the treatment of various cancers, consistent radiation emission, and effective tumor control.
Popularity of iodine-125 seeds can be attributed to proven efficacy, reliable performance, and widespread availability, making them a preferred choice among healthcare providers and patients in the field of brachytherapy.
Based on technique, the HRD brachytherapy segment is likely to dominate the global industry during the forecast period. HRD brachytherapy involves delivery of a high dose of radiation over a short period, typically using a remote afterloader system. This technique offers advantages such as precise dose delivery, reduced treatment time, and improved patient convenience.
Rise in adoption of HRD brachytherapy, driven by advancements in technology and increasing demand for efficient treatment options, is likely to contribute to the segment's dominance in the global industry.
In terms of application, the prostate cancer segment is anticipated to account for leading share of the global market during the forecast period. Brachytherapy, particularly in the form of permanent seed implants, has emerged as a highly effective treatment option for localized prostate cancer. It offers precise targeting of the tumor while minimizing damage to surrounding healthy tissues.
Increase in incidence of prostate cancer and surge in preference for minimally invasive treatments has fueled the adoption of brachytherapy in prostate cancer management.
In terms of end-user, the hospitals segment is anticipated to account for leading share of the global market during the forecast period. As the primary healthcare institutions responsible for cancer treatment, hospitals are key players in the adoption and utilization of brachytherapy procedures. These possess the necessary infrastructure, specialized equipment, and skilled healthcare professionals required to perform brachytherapy effectively.
According to the latest brachytherapy seeds market trends, North America is expected to account for the largest market share from 2023 to 2031. The region's dominance can be ascribed to well-established healthcare infrastructure and high awareness about cancer treatment options.
North America has a significant presence of key market players and research institutions, driving technological advancements and innovation in brachytherapy seeds. Favorable reimbursement policies and government initiatives to promote cancer care are propelling brachytherapy seeds market demand in North America.
The market in Asia Pacific is expected to witness robust growth during the forecast period. Large and rapidly increasing population, rise in urbanization, and improving healthcare infrastructure are driving the market in the region.
Increase in healthcare expenditure, growing middle-class population, and surge in awareness about advanced healthcare solutions are driving demand for brachytherapy seeds in Asia Pacific.
Companies in the market focus on strategies such as mergers and partnerships & collaborations to compete in the marketplace. Argon Medical, Carl Zeiss AG, Eckert & Ziegler BEBIG, Elekta AB, Icad, Inc., Mislaid, Isoray Medical, Inc., Merit Medical Systems, Inc., Siemens AG, and Theragenics Corporation are the prominent players in the market.
Each of these players has been profiled in the brachytherapy seeds market research report based on parameters such as company overview, financial overview, product portfolio, business strategies, business segments, and recent developments.
| Attribute | Detail |
|---|---|
|
Size in 2022 |
US 132.2 Mn |
|
Forecast (Value) in 2031 |
More than US$ 191.4 Mn |
|
Growth Rate (CAGR) |
4.1% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 132.2 Mn in 2022.
It is projected to reach more than US$ 191.4 Mn by 2031.
The market is anticipated to grow at a CAGR of 4.1% from 2023 to 2031.
Increase in incidence of cancer, rise in preference for minimally invasive treatments, and advancements in brachytherapy techniques are propelling the market.
The iodine-125 segment accounted for more than 42.7% market share in 2022.
North America is expected to account for the largest share of the market from 2023 to 2031.
Argon Medical, Carl Zeiss AG, Eckert & Ziegler BEBIG, Elekta AB, Icad, Inc., Mislaid, Isoray Medical, Inc., Merit Medical Systems, Inc., Siemens AG, and Theragenics Corporation are the prominent players in the market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Brachytherapy Seeds Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Brachytherapy Seeds Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Key Radioactive Seed Type/Brand Analysis
5.3. Patent Analysis
5.4. Top 3 Players Operating in the Market Space
5.5. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Brachytherapy Seeds Market Analysis and Forecast, by Radioactive Seed Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Radioactive Seed Type, 2017-2031
6.3.1. Iodine-125
6.3.2. Palladium-103
6.3.3. Cesium-131
6.3.4. Others
6.4. Market Attractiveness Analysis, by Radioactive Seed Type
7. Global Brachytherapy Seeds Market Analysis and Forecast, by Technique
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technique, 2017-2031
7.3.1. HRD Brachytherapy
7.3.2. LDR Brachytherapy
7.4. Market Attractiveness Analysis, by Technique
8. Global Brachytherapy Seeds Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
8.3.1. Gynecological Cancer
8.3.2. Prostate Cancer
8.3.3. Breast Cancer
8.3.4. Brain Cancer
8.3.5. Others
8.4. Market Attractiveness Analysis, by Application
9. Global Brachytherapy Seeds Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Cancer Institutes
9.3.3. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Brachytherapy Seeds Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017-2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Region
11. North America Brachytherapy Seeds Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
11.2.1. Iodine-125
11.2.2. Palladium-103
11.2.3. Cesium-131
11.2.4. Others
11.3. Market Value Forecast, by Technique, 2017-2031
11.3.1. HRD Brachytherapy
11.3.2. LDR Brachytherapy
11.4. Market Value Forecast, by Application, 2017-2031
11.4.1. Gynecological Cancer
11.4.2. Prostate Cancer
11.4.3. Breast Cancer
11.4.4. Brain Cancer
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Cancer Institutes
11.5.3. Others
11.6. Market Value Forecast, by Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Radioactive Seed Type
11.7.2. By Technique
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Brachytherapy Seeds Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
12.2.1. Iodine-125
12.2.2. Palladium-103
12.2.3. Cesium-131
12.2.4. Others
12.3. Market Value Forecast, by Technique, 2017-2031
12.3.1. HRD Brachytherapy
12.3.2. LDR Brachytherapy
12.4. Market Value Forecast, by Application, 2017-2031
12.4.1. Gynecological Cancer
12.4.2. Prostate Cancer
12.4.3. Breast Cancer
12.4.4. Brain Cancer
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Cancer Institutes
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Radioactive Seed Type
12.7.2. By Technique
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Brachytherapy Seeds Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
13.2.1. Iodine-125
13.2.2. Palladium-103
13.2.3. Cesium-131
13.2.4. Others
13.3. Market Value Forecast, by Technique, 2017-2031
13.3.1. HRD Brachytherapy
13.3.2. LDR Brachytherapy
13.4. Market Value Forecast, by Application, 2017-2031
13.4.1. Gynecological Cancer
13.4.2. Prostate Cancer
13.4.3. Breast Cancer
13.4.4. Brain Cancer
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Cancer Institutes
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Radioactive Seed Type
13.7.2. By Technique
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Brachytherapy Seeds Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
14.2.1. Iodine-125
14.2.2. Palladium-103
14.2.3. Cesium-131
14.2.4. Others
14.3. Market Value Forecast, by Technique, 2017-2031
14.3.1. HRD Brachytherapy
14.3.2. LDR Brachytherapy
14.4. Market Value Forecast, by Application, 2017-2031
14.4.1. Gynecological Cancer
14.4.2. Prostate Cancer
14.4.3. Breast Cancer
14.4.4. Brain Cancer
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Cancer Institutes
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Radioactive Seed Type
14.7.2. By Technique
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Brachytherapy Seeds Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Radioactive Seed Type, 2017-2031
15.2.1. Iodine-125
15.2.2. Palladium-103
15.2.3. Cesium-131
15.2.4. Others
15.3. Market Value Forecast, by Technique, 2017-2031
15.3.1. HRD Brachytherapy
15.3.2. LDR Brachytherapy
15.4. Market Value Forecast, by Application, 2017-2031
15.4.1. Gynecological Cancer
15.4.2. Prostate Cancer
15.4.3. Breast Cancer
15.4.4. Brain Cancer
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Cancer Institutes
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Radioactive Seed Type
15.7.2. By Technique
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2021
16.3. Company Profiles
16.3.1. Argon Medical
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Carl Zeiss AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Eckert & Ziegler BEBIG
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Elektra AB
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Icad, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Isoaid
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Isoray Medical, Inc.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Merit Medical Systems, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Siemens AG
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Theragenics Corporation
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 01: Global Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Radioactive Seed Type, 2017-2031
Table 02: Global Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Technique, 2017-2031
Table 03: Global Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 04: Global Brachytherapy Seeds Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 07: North America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Radioactive Seed Type, 2017-2031
Table 08: North America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Technique, 2017-2031
Table 09: North America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 10: North America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Radioactive Seed Type, 2017-2031
Table 13: Europe Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 14: Europe Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Technique, 2017-2031
Table 15: Europe Brachytherapy Seeds Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Radioactive Seed Type, 2017-2031
Table 18: Asia Pacific Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Technique, 2017-2031
Table 19: Asia Pacific Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 20: Asia Pacific Brachytherapy Seeds Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Radioactive Seed Type, 2017-2031
Table 23: Latin America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Technique, 2017-2031
Table 24: Latin America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 25: Latin America Brachytherapy Seeds Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Radioactive Seed Type, 2017-2031
Table 28: Middle East & Africa Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Technique, 2017-2031
Table 29: Middle East & Africa Brachytherapy Seeds Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 30: Middle East & Africa Brachytherapy Seeds Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Brachytherapy Seeds Market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Brachytherapy Seeds Market Value Share, by Radioactive Seed Type, 2022
Figure 03: Global Brachytherapy Seeds Market Value Share, by Application, 2022
Figure 04: Global Brachytherapy Seeds Market Value Share, by End-user, 2022
Figure 05: Global Brachytherapy Seeds Market Value Share, by Region, 2022
Figure 06: Global Brachytherapy Seeds Market Value Share Analysis, by Radioactive Seed Type, 2022 and 2031
Figure 07: Global Brachytherapy Seeds Market Attractiveness Analysis, by Radioactive Seed Type, 2023-2031
Figure 08: Global Brachytherapy Seeds Market Revenue (US$ Mn), by Iodine-125, 2017-2031
Figure 09: Global Brachytherapy Seeds Market Revenue (US$ Mn), by Palladium-103, 2017-2031
Figure 10: Global Brachytherapy Seeds Market Revenue (US$ Mn), by Cesium-131, 2017-2031
Figure 11: Global Brachytherapy Seeds Market Revenue (US$ Mn), by Others, 2017-2031
Figure 12: Global Brachytherapy Seeds Market Value Share Analysis, by Technique, 2022 and 2031
Figure 13: Global Brachytherapy Seeds Market Attractiveness Analysis, by Technique, 2023-2031
Figure 14: Global Brachytherapy Seeds Market Revenue (US$ Mn), by HRD Brachytherapy, 2017-2031
Figure 15: Global Brachytherapy Seeds Market Revenue (US$ Mn), by LDR Brachytherapy, 2017-2031
Figure 16: Global Brachytherapy Seeds Market Value Share Analysis, by Application, 2017-2031
Figure 17: Global Brachytherapy Seeds Market Attractiveness Analysis, by Application, 2023-2031
Figure 18: Global Brachytherapy Seeds Market Value Share Analysis, by End-user, 2022 and 2031
Figure 19: Global Brachytherapy Seeds Market Attractiveness Analysis, by End-user, 2023-2031
Figure 20: Global Brachytherapy Seeds Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Brachytherapy Seeds Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Brachytherapy Seeds Market Value (US$ Mn) Forecast, 2017-2031
Figure 23: North America Brachytherapy Seeds Market Value Share Analysis, by Country, 2022 and 2031
Figure 24: North America Brachytherapy Seeds Market Attractiveness Analysis, by Country, 2023-2031
Figure 25: North America Brachytherapy Seeds Market Value Share Analysis, by Radioactive Seed Type, 2022 and 2031
Figure 26: North America Brachytherapy Seeds Market Attractiveness Analysis, by Radioactive Seed Type, 2023-2031
Figure 27: North America Brachytherapy Seeds Market Value Share Analysis (US$ Mn), by Application, 2017-2031
Figure 28: North America Brachytherapy Seeds Market Attractiveness Analysis, by Application, 2023-2031
Figure 29: North America Brachytherapy Seeds Market Value Share Analysis, by End-user, 2022 and 2031
Figure 30: North America Brachytherapy Seeds Market Attractiveness Analysis, by End-user, 2023-2031
Figure 31: Europe Brachytherapy Seeds Market Value (US$ Mn) Forecast, 2017-2031
Figure 32: Europe Brachytherapy Seeds Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 33: Europe Brachytherapy Seeds Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 34: Europe Brachytherapy Seeds Market Value Share Analysis, by Radioactive Seed Type, 2022 and 2031
Figure 35: Europe Brachytherapy Seeds Market Attractiveness Analysis, by Radioactive Seed Type, 2023-2031
Figure 36: Europe Brachytherapy Seeds Market Value Share Analysis, by Application, 2017-2031
Figure 37: Europe Brachytherapy Seeds Market Attractiveness Analysis, by Application, 2023-2031
Figure 38: Europe Brachytherapy Seeds Market Value Share Analysis, by End-user, 2022 and 2031
Figure 39: Europe Brachytherapy Seeds Market Attractiveness Analysis, by End-user, 2023-2031
Figure 40: Asia Pacific Brachytherapy Seeds Market Value (US$ Mn) Forecast, 2017-2031
Figure 41: Asia Pacific Brachytherapy Seeds Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Asia Pacific Brachytherapy Seeds Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 43: Asia Pacific Brachytherapy Seeds Market Value Share Analysis, by Radioactive Seed Type, 2022 and 2031
Figure 44: Asia Pacific Brachytherapy Seeds Market Attractiveness Analysis, by Radioactive Seed Type, 2023-2031
Figure 45: Asia Pacific Brachytherapy Seeds Market Value Share Analysis, by Application, 2017-2031
Figure 46: Asia Pacific Brachytherapy Seeds Market Attractiveness Analysis, by Application, 2023-2031
Figure 47: Asia Pacific Brachytherapy Seeds Market Value Share Analysis, by End-user, 2022 and 2031
Figure 48: Asia Pacific Brachytherapy Seeds Market Attractiveness Analysis, by End-user, 2023-2031
Figure 49: Latin America Brachytherapy Seeds Market Value (US$ Mn) Forecast, 2017-2031
Figure 50: Latin America Brachytherapy Seeds Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 51: Latin America Brachytherapy Seeds Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 52: Latin America Brachytherapy Seeds Market Value Share Analysis, by Radioactive Seed Type, 2022 and 2031
Figure 53: Latin America Brachytherapy Seeds Market Attractiveness Analysis, by Radioactive Seed Type, 2023-2031
Figure 54: Latin America Brachytherapy Seeds Market Value Share Analysis, by Application, 2017-2031
Figure 55: Latin America Brachytherapy Seeds Market Attractiveness Analysis, by Application, 2023-2031
Figure 56: Latin America Brachytherapy Seeds Market Value Share Analysis, by End-user, 2022 and 2031
Figure 57: Latin America Brachytherapy Seeds Market Attractiveness Analysis, by End-user, 2023-2031
Figure 58: Middle East & Africa Brachytherapy Seeds Market Value (US$ Mn) Forecast, 2017-2031
Figure 59: Middle East & Africa Brachytherapy Seeds Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 60: Middle East & Africa Brachytherapy Seeds Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 61: Middle East & Africa Brachytherapy Seeds Market Value Share Analysis, by Radioactive Seed Type, 2022 and 2031
Figure 62: Middle East & Africa Brachytherapy Seeds Market Attractiveness Analysis, by Radioactive Seed Type, 2023-2031
Figure 63: Middle East & Africa Brachytherapy Seeds Market Value Share Analysis, by Application, 2017-2031
Figure 64: Middle East & Africa Brachytherapy Seeds Market Attractiveness Analysis, by Application, 2023-2031
Figure 65: Middle East & Africa Brachytherapy Seeds Market Value Share Analysis, by End-user, 2022 and 2031
Figure 66: Middle East & Africa Brachytherapy Seeds Market Attractiveness Analysis, by End-user, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Brachytherapy Seeds Market
*86 figures and 60 tables includes